CAMBRIDGE, Mass., March 31, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology ...
CAMBRIDGE, Mass., March 31, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology ...
CAMBRIDGE, Mass., March 31, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology ...
STAMFORD, Conn., March 31, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company ...
In a release issued under the same headline earlier today by FLX Bio, Inc., please note ...
Medical Prognosis Institute A/S ("MPI") publishes the Annual Report for 2016. For the complete ...
New data on Halioseek(TM) PD-L1/CD8 presented at AACR 2017 HalioDx has developed an assay ...
Outpatient visits for influenza-like illness (ILI) held steady for the week ending March 25, ...
More work needs to be done to address the shortage of psychiatrists, including improvements ...
Preclinical models of elacestrant activity in preclinical models of endocrine treatment resistancePreclinical studies of ...
FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Occult cancers accounted for one in about every 12 ...
AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – Patients who experience an acute MI ...
SOUTH SAN FRANCISCO, Calif., March 31, 2017 (GLOBE NEWSWIRE) -- FLX Bio, Inc., a ...